Posts by growthzone
BIO: Why the TRIPS waiver wouldn’t work
BIO President and CEO Dr. Michelle McMurry-Heath sent a letter April 19 to U.S. Trade Representative Ambassador Katherine Tai to explain why the WTO’s proposed “TRIPS waiver” would have global health and economic consequences as the pandemic rages on.
Read MoreCED Venture Connect 2021 draws a virtual crowd
Like last year, this year’s Venture Connect held March 23-25 produced by the Council for Entrepreneurial Development took place entirely online but with many new features. NCBIO is a sponsor of Venture Connect, which connects life science and technology companies in the Southeast with investors, sponsors and fellow entrepreneurs to network, discuss innovative technologies and…
Read MoreSam Taylor honored in the Congressional Record
REMEMBERING SAM TAYLOR Mr. Tillis. Madam President, I rise today with my colleague, the senior Senator from North Carolina, to honor the life and work of Sam Taylor, the president of North Carolina Biosciences Organization. Sam was a giant in our State and a leading voice for our vital and innovative life sciences and biopharmaceutical…
Read MoreNC legislators discuss workforce with NCBIO members during BMF meeting
NCBIO manufacturing companies discussed their workforce needs with North Carolina state legislators during the quarterly meeting of the NCBIO Biotech Manufacturers Forum held online Tuesday, March 2. Representatives of Biogen, FUJIFILM DioSynth, Grifols, Merck, Novartis, Novozymes and Pfizer were among those who spoke to leaders of the NC General Assembly’s Life Sciences Caucus. Caucus co-chairs…
Read MoreNCBIO webinar discusses hiring during pandemic
On Wednesday, Feb. 24, NCBIO hosted a webinar on “New Dynamics in Talent Recruitment” as part of the NCBIO Life Sciences Forums. Panelists discussed the challenges and opportunities that have arisen in recruiting and retaining employees during the pandemic. Stephen Williams, practice lead, North Carolina sciences at Aerotek, served as moderator of a panel comprising…
Read MoreRemembering Sam Taylor
Remembering Sam Taylor “As champion of economic development through the life sciences, including small business, Sam Taylor was a tremendous leader, tireless advocate and loyal partner that the North Carolina Board of Science, Technology & Innovation was grateful to work with. Sam’s legacy created economic opportunities that benefitted the state and improved the livelihood of…
Read MoreSam Taylor, leading advocate for NC’s biosciences industry, dies at 64
Sam Taylor, an unflagging advocate for North Carolina and its biosciences industry as president of NCBIO, died Sunday, Feb. 21, at the age of 64 of pancreatic cancer.
Read MoreLaunchBio webinar explores diversity in life-science venture capitalism
On Wednesday, Feb. 17, LaunchBio hosted a webinar discussing diversity in life science venture capitalism.
Read MoreExecutive order on drug prices does no favors for NC patients, hospitals
A new executive order that slashes Medicare payments to hospitals and physicians for certain medicines will hurt patients’ access to care and financially stress already overburdened hospitals and innovation-based pharmaceutical companies
Read More